申请人:Merck Sharp & Dohme Corp.
公开号:EP2546232A1
公开(公告)日:2013-01-16
The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors:
Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
本发明提供的式 I 化合物是 5-脂氧合酶活化蛋白抑制剂:
式 I 化合物可用作抗动脉粥样硬化、抗哮喘、抗过敏、抗炎和细胞保护剂。